Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Exemestane + Sapu003 |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Exemestane | Aromasin | Aromatase Inhibitor 3 | Aromasin (exemestane) is an aromatase inhibitor, which prevents the conversion of androgenic precursors to estrogens (NCI Drug Dictionary). | |
| Sapu003 | Sapu003 is a nanoparticle formulation of Everolimus, which enables intravenous delivery and may improve bioavailability and efficacy (Clin Cancer Res (2026) 32 (4_Supplement): PS4-06-05). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07369505 | Phase I | Sapu003 Exemestane + Sapu003 | Sapu003 in Advanced mTOR-sensitive Solid Tumors | Recruiting | AUS | 0 |